JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Transcranial Doppler monitoring after carotid endarterectomy.

The objectives of this study were to evaluate the feasibility of transcranial Doppler (TCD) monitoring after carotid endarterectomy (CEA) and to investigate whether 1 hr of monitoring is sufficient to detect a clinically relevant change in the number of postoperative microemboli. We also evaluated the association of patient characteristics and procedure-related variables with the number of postoperative microemboli. One hundred and two patients were monitored during the second hour after CEA. The main outcome measure was the number of TCD-detected microemboli. The secondary outcome measure was a procedure-related cerebral complication graded according to the modified Rankin scale. The median number of microemboli during the second postoperative hour was two (interquartile ranges, 0.75-11) and decreased in most the patients during this time. Two patients had a relatively high and increasing number of microemboli and developed a minor stroke after a symptom-free interval. One patient developed a TIA intraoperatively. There was no significant association between patient characteristics and the use of a venous patch and the number of postoperative microemboli. Conversely, a statistically significant negative association was found between shunt use and the number of microemboli (p = 0.02). The majority of patients had no or a small and decreasing number of microemboli. One hour of monitoring appeared to be effective to select those patients in whom the number of microemboli did not spontaneously decrease and who may need additional medical treatment or surgical reexploration. The role of TCD-detected microemboli as a surrogate measure for the risk of stroke after CEA remains to be validated.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app